Prognostic value of the MELD-XI score in patients undergoing cardiac resynchronization therapy.

ABSTRACT:

Aims

Multi-organ dysfunction was recently reported to be a common condition in patients with heart failure (HF). The Model for End-stage Liver Disease eXcluding International normalized ratio (MELD-XI) score reflects liver and kidney function. The prognostic relevance of this score has been reported in patients with a variety of cardiovascular diseases who are undergoing interventional therapies. However, the relationship between the severity of hepatorenal dysfunction assessed by the MELD-XI score and the long-term clinical outcomes of HF patients receiving cardiac resynchronization therapy (CRT) has not been evaluated.

Methods and results

Clinical records of 283 patients who underwent CRT implantation between March 2003 and October 2020 were retrospectively evaluated (mean

SUBMITTER: Saito Y 

PROVIDER: S-EPMC8934924 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature